Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmatimes.com/news/nice_recommends_cenobamate_for_treatment_of_adult_epilepsy_patients_in_uk_1383466
http://www.pharmafile.com/news/570444/ema-recommends-arvelles-seizure-drug-cenobamate
https://www.prnewswire.com/news-releases/angelini-pharma-acquires-arvelle-therapeutics-to-create-a-leading-european-innovator-in-central-nervous-system-cns-and-mental-health-disorder-treatments-301207862.html
https://www.angelinipharma.com/media/press-releases/angelini-pharma-acquires-arvelle-therapeutics/
https://www.globenewswire.com/news-release/2020/05/26/2038483/0/en/Arvelle-Announces-Closing-of-Final-Tranche-of-Series-A-Financing-Round.html
https://www.globenewswire.com/news-release/2020/08/17/2078998/0/en/Arvelle-Announces-Partnership-with-Durbin-Across-Europe.html#:~:text=Zug%2C%20Switzerland%2C%2017%20August%202020,for%20the%20distribution%20of%20cenobamate
https://www.globenewswire.com/news-release/2020/05/21/2036784/0/en/Results-of-a-Randomised-Study-Showing-that-Adjunctive-Cenobamate-Significantly-Improved-Seizure-control-in-Adults-with-Uncontrolled-Focal-Seizures-Published-in-Neurology-1.html
https://www.globenewswire.com/news-release/2020/03/26/2007048/0/en/Arvelle-Announces-European-Medicines-Agency-Acceptance-of-the-Marketing-Authorization-Application-for-Cenobamate.html